Integrative Analysis of Epidemiological Profile of Sensitization Clinical Laboratory Markers in Children: Cross-Sectional Study Results
https://doi.org/10.15690/pf.v18i2.2251
Abstract
Background. The prevalence of various allergic diseases has increased worldwide in recent decades. Allergy diagnosis in children should be economically optimal and as sparing as possible, while ensuring the high quality of medical care. Objective. The aim of the study is to develop optimal algorithms for analysis of sensitization profile in children with allergy family history, or suspected allergy, or atopy phenotype. Methods. Complete examination of 153 children aged from 1 to 17 years 11 months was performed. Children were divided in 4 groups according to the presence and characteristics of complaints, the presence of allergic disease. Sensitization was determined via the “gold standard” of allergy diagnosis — the ImmunoCap method (Phadia, Sweden), and the results of skin testing. Results. 97 (63.4%) children have shown sensitization to various allergens. We have revealed seasonal manifestation of allergy in children to various allergens: Fagales in 89-92% of cases, grasses in 68-72% of cases, weeds in 39-57% of cases. Complaints of all-year manifestations of allergic rhinitis were revealed in 24% of cases to cat dandruff, complaints of coughing and/or bronchospasm — in 100% of cases to birch pollen and in 35% of cases to house dust. The sensitization analysis has revealed strong correlations with confirmed statistical significance between pollen allergen sensitization classes in groups of different plants. Conclusion. Optimal algorithms for sensitization diagnosis in children living in Moscow agglomeration were developed according to the obtained results and revealed correlations.
About the Authors
L. G. LevinaRussian Federation
Julia G. Levina
Moscow
Disclosure of interest:
Authors confirmed the absence of a reportable conflict of interests.
L. S. Namazova-Baranova
Russian Federation
Leyla S. Namazova-Baranova
Moscow; Belgorod
Disclosure of interest:
Receiving research grants from pharmaceutical companies Pierre Fabre LLC, GenzymeEurope B.V., AstraZeneca PLC, Gilead / PRA “P eutical Research Associates CIS”, Teva Branded Pharmaceutical products R&D, Inc / “PPD Development LLC (Smolensk)” LLC, “Stallerzhen S.A.” / “Quintiles GMBH” (Austria), Sanofi Aventis Group LLC, Bionorica LLC, Nutricia LLC.
E. A. Vishneva
Russian Federation
Elena A. Vishneva
Moscow
Disclosure of interest:
Authors confirmed the absence of a reportable conflict of interests.
K. S. Volkov
Russian Federation
Konstantin S. Volkov
Moscow
Disclosure of interest:
Authors confirmed the absence of a reportable conflict of interests.
K. Y. Efendieva
Russian Federation
Kamilla Y. Efendieva
Moscow
Disclosure of interest:
Authors confirmed the absence of a reportable conflict of interests.
A. A. Alekseeva
Russian Federation
Anna A. Alekseeva
Moscow
Disclosure of interest:
Authors confirmed the absence of a reportable conflict of interests.
V. G. Kalugina
Russian Federation
Vera G. Kalugina
Moscow
Disclosure of interest:
Authors confirmed the absence of a reportable conflict of interests.
P. S. Arimova
Russian Federation
Polina S. Arimova
Disclosure of interest:
Authors confirmed the absence of a reportable conflict of interests.
References
1. Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050ff.ffhal-01760836f
2. Global Strategy for Asthma Management and Prevention Updated 2020. Global Initiative on Asthma; 2020. Available online: https://ginasthma.org/wp-content/uploads/2020/04/GINA2020-full-report_-final-_wms.pdf. Accessed on May 20, 2021.
3. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. doi: 10.1111/jdv.14891
4. Allergologiya i immunologiya / NamazovaBaranova LS, Baranov AA, Khaitov RM, eds. Moscow: Union of Pediatricians of Russia; 2020. (In Russ).
5. Pawankar R. Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organ J. 2014;7(1):12. doi: 10.1186/1939-4551-7-12
6. Bousquet J, Gern JE, Martinez FD, et al. Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop. J Allergy Clin Immunol. 2014;133(6):1535–1546. doi: 10.1016/j.jaci.2014.01.018
7. Lopatin AS, Chuchueva ND. Prevalence of allergic rhinitis in Russia and all over the world. Russian Journal of Allergy. 2013;(2):3–11. (In Russ).
8. Kozulina IE, Kurbachevа OM, Ilina NI. Allergy today. Analysis of new epidemiological data. Russian Journal of Allergy. 2014;(3):3–10. (In Russ).
9. Peternel R., Toth I., Hercog P. Influence of aeroallergens on the Incidence of conjunctivitis in Zagreb and Zagreb County. Coll Antropol. 2013;37(Suppl 1):13–17.
10. Allergologiya i immunologiya: Clinical guidelines for pediatricians. Baranov AA, Namazova-Baranova LS, Khaitov RM, eds. Moscow: Pediatr; 2018. 492 p. (In Russ).
11. Navarro A. Rinitis. In: SEAIC & Schering-Plough editores. Factores epidemiologicos, clinicos y socioeconomicos de las enfermedadesalergicas en Espana en 2005. Madrid: Luzan 5, S.A. Ediciones; 2006. pp.107–131.
12. Akdis CA, Agache I. EAACI Global Atlas of Allergy. Zurich: The European Academy of Allergy and Clinical Immunology; 2014. 406 p. Available online: https://www.zora.uzh.ch/id/eprint/140934/1/GlobalAtlasAllergy.pdf. Accessed on May 20, 2021.
13. Fernandez-Rivas M, Aalbers M, Fötisch K, et al. Immune reactivity of candidate reference materials. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2006;(95):84–88.
14. Konradsen JR, Fujisawa T, van Hage M, et al. Allergy to furry animals: New insights, diagnostic approaches, and challenges. J Allergy Clin Immunol. 2015;135(3):616–625. doi: 10.1016/j.jaci.2014.08.026
15. Suzuki S, Nwaru BI, Ekerljung L, et al. Characterization of sensitization to furry animal allergen components in an adult population. Clin Exp Allergy. 2019;49(4):495–505. doi: 10.1111/cea.13355
16. Chan SK, Leung DYM. Dog and Cat Allergies: Current State of Diagnostic Approaches and Challenges. Allergy Asthma Immunol Res. 2018;10(2):97–105. doi: 10.4168/aair.2018.10.2.97
17. Namazova-Baranova LS, Efendieva KY, Levina JG, et al. Innovative Management Methods for Patients Allergic to Cats. Voprosy sovremennoi pediatrii — Current Pediatrics. 2020;19(4):316–324. (In Russ). doi: 10.15690/vsp.v19i4.2136
18. Oluwole O, Arinola GO, Ana GR, et al. Relationship between household air pollution from biomass smoke exposure, and pulmonary dysfunction, oxidant-antioxidant imbalance and systemic inflammation in rural women and children in Nigeria. Glob J Health Sci. 2013;5(4):28–38. doi: 10.5539/gjhs.v5n4p28
19. Kabengele BO, Kayembe JM, Kayembe PK, et al. Factors associated with uncontrolled asthma in adult asthmatics in Kinshasa, Democratic Republic of Congo. PLoS ONE. 2019;14(14):e0215530. doi: 10.1371/journal.pone.0215530
20. Где живёт больше всего кошек? // CatPeople. — 2020. [Gde zhivet bol’she vsego koshek? CatPeople. 2020. (In Russ).] Доступно по: http://catpeople.ru/catification/gde-zhivyot-bolshe-vsegokoshek.html. Ссылка активна на 20.05Accessed August 1, .2021.
21. Asarnoj A, Hamsten C, Wadén K, et al. Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study. J Allergy Clin Immunol. 2016;137(3):813–821.e7. doi: 10.1016/j.jaci.2015.09.052
22. Nissen SP, Kjaer HF, Høst A, et al. The natural course of sensitization and allergic diseases from childhood to adulthood. Pediatr Allergy Immunol. 2013;24(6):549–555. doi: 10.1111/pai.12108
23. Hesselmar B, Aberg N, Aberg B, et al. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy. 1999;29(5):611–617. doi: 10.1046/j.1365-2222.1999.00534.x
24. Ichikawa K, Iwasaki E, Baba M, Chapman MD. High prevalence of sensitization to cat allergen among Japanese children with asthma, living without cats. Clin Exp Allergy. 1999;29(6):754–761. doi: 10.1046/j.1365-2222.1999.00472.x
25. Satyaraj E, Wedner HJ, Bousquet J. Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen. Allergy. 2019;74 (Suppl 107):5–17. doi: 10.1111/all.14013
26. Allergiya u detei. Ot teorii k praktike. Namazova-Baranova LS, ed. Moscow: Union of Pediatricians of Russia; 2011. (In Russ).
27. Snovskaya MA, Namazova-Baranova LS, Kozhevnikova OV, et al. The mode of evaluation of sensitization of children to grain herbs under respiratory allergy Klinicheskaya Laboratornaya Diagnostika =Russian Clinical Laboratory Diagnostics. 2017;62(5):300–304. (In Russ). doi: 10.18821/0869-2084-2017-5-300-304
28. Hamilton RG, Adkinson FN Jr. In vitro assays for the diagnosis of IgE-mediated disorders. J Allergy Clin Immunol. — 2004. — 114:213.
29. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, et al. EAACI Molecular Allergology User’s Guide. Pediatr Allergy Immunol. 2016;27Х( Suppl 23):1–250. doi: 10.1111/pai.12563
30. Diaz-Vazquez C, Torregrosa-Bertet MJ, Carvajal-Urueña I, et al. Accuracy of ImmunoCAP Rapid in the diagnosis of allergic sensitization in children between 1 and 14 years with recurrent wheezing: the IReNE study. Pediatr Allergy Immunol. 2009;20(6):601–609. doi: 10.1111/j.1399-3038.2008.00827.x
31. Gadisseur R, Chapelle J.P., Cavalier E. A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP© 250 with the ImmunoCAP© ISAC. Clin Chem Lab Med. 2011;49(2):277–280. doi: 10.1515/CCLM.2011.052
32. Lorenz AR, Lüttkopf D, May S, et al. The principle of homologous groups in regulatory affairs of allergen productsa proposal. Int Arch Allergy Immunol. 2009;148(1):1–17. doi: 10.1159/000151243
33. Kleine-Tebbe J, Zuberbier T, Werfel T, et al. Is allergy immunotherapy with birch sufficient to treat patients allergic to pollen of tree species of the birch homologous group? Allergy. 2020;75(6):1327–1336. doi: 10.1111/all.14130
Review
For citations:
Levina L.G., Namazova-Baranova L.S., Vishneva E.A., Volkov K.S., Efendieva K.Y., Alekseeva A.A., Kalugina V.G., Arimova P.S. Integrative Analysis of Epidemiological Profile of Sensitization Clinical Laboratory Markers in Children: Cross-Sectional Study Results. Pediatric pharmacology. 2021;18(2):118-133. (In Russ.) https://doi.org/10.15690/pf.v18i2.2251